Hugo Tempelman

986 total citations
14 papers, 340 citations indexed

About

Hugo Tempelman is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Hugo Tempelman has authored 14 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 11 papers in Virology and 3 papers in Epidemiology. Recurrent topics in Hugo Tempelman's work include HIV Research and Treatment (11 papers), HIV/AIDS Research and Interventions (11 papers) and HIV/AIDS drug development and treatment (8 papers). Hugo Tempelman is often cited by papers focused on HIV Research and Treatment (11 papers), HIV/AIDS Research and Interventions (11 papers) and HIV/AIDS drug development and treatment (8 papers). Hugo Tempelman collaborates with scholars based in Netherlands, South Africa and Canada. Hugo Tempelman's co-authors include Annemarie M. J. Wensing, Sibyl P. M. Geelen, Andy I. M. Hoepelman, Roos E. Barth, W.L.J.M. Devillé, Pieter W. Smit, Mathilde E. Boon, Frank Schuren, Remco Kort and Erik M. van Bussel and has published in prestigious journals such as PLoS ONE, Scientific Reports and American Journal of Obstetrics and Gynecology.

In The Last Decade

Hugo Tempelman

13 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hugo Tempelman Netherlands	8	236	170	113	65	49	14	340
Chuong Dinh United States	12	284 1.2×	184 1.1×	110 1.0×	118 1.8×	34 0.7×	32	376
Richard E. Haaland United States	10	177 0.8×	77 0.5×	100 0.9×	53 0.8×	23 0.5×	23	249
Diane Valéa Burkina Faso	12	298 1.3×	286 1.7×	164 1.5×	27 0.4×	22 0.4×	14	459
Erastus Irungu Canada	6	116 0.5×	178 1.0×	102 0.9×	111 1.7×	48 1.0×	15	347
Manjeetha Jaggernath United States	11	178 0.8×	103 0.6×	133 1.2×	58 0.9×	110 2.2×	17	369
Ratiya Pamela Kunjara Na Ayudhya United States	6	177 0.8×	128 0.8×	93 0.8×	122 1.9×	42 0.9×	9	299
Wanna Leelawiwat Thailand	10	246 1.0×	176 1.0×	167 1.5×	33 0.5×	29 0.6×	21	333
Marineide Gonçalves de Melo Brazil	10	237 1.0×	72 0.4×	186 1.6×	30 0.5×	85 1.7×	36	334
Jennifer Malia United States	10	229 1.0×	159 0.9×	139 1.2×	17 0.3×	28 0.6×	19	309
Mireille Kalou United States	12	338 1.4×	258 1.5×	171 1.5×	24 0.4×	25 0.5×	20	450

Countries citing papers authored by Hugo Tempelman

Since Specialization

Citations

This map shows the geographic impact of Hugo Tempelman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugo Tempelman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugo Tempelman more than expected).

Fields of papers citing papers by Hugo Tempelman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hugo Tempelman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugo Tempelman. The network helps show where Hugo Tempelman may publish in the future.

Co-authorship network of co-authors of Hugo Tempelman

This figure shows the co-authorship network connecting the top 25 collaborators of Hugo Tempelman. A scholar is included among the top collaborators of Hugo Tempelman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hugo Tempelman. Hugo Tempelman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

1.

Hermans, Lucas E., Neeltje A. Kootstra, Irma Maurer, et al.. (2024). Defective proviruses significantly impact viral transcription and immune activation in men and women with HIV-1 subtype C in rural South Africa. Frontiers in Immunology. 15. 1484358–1484358. 5 indexed citations

2.

Nel, Annaléne, Neliëtte van Niekerk, Ben Van Baelen, et al.. (2021). Safety, adherence, and HIV-1 seroconversion among women using the dapivirine vaginal ring (DREAM): an open-label, extension study. The Lancet HIV. 8(2). e77–e86. 71 indexed citations

3.

Connell, Bridgette J., Lucas E. Hermans, Annemarie M. J. Wensing, et al.. (2020). Immune activation correlates with and predicts CXCR4 co-receptor tropism switch in HIV-1 infection. Scientific Reports. 10(1). 15866–15866. 24 indexed citations

4.

Devillé, W.L.J.M. & Hugo Tempelman. (2019). Feasibility and robustness of an oral HIV self-test in a rural community in South-Africa: An observational diagnostic study. PLoS ONE. 14(4). e0215353–e0215353. 21 indexed citations

5.

Revell, Andrew, Dechao Wang, Maria Jesús Pérez‐Elías, et al.. (2019). Predicting Virological Response to HIV Treatment Over Time: A Tool for Settings With Different Definitions of Virological Response. JAIDS Journal of Acquired Immune Deficiency Syndromes. 81(2). 207–215.

6.

Revell, Andrew, Dechao Wang, Robin Wood, et al.. (2016). An update to the HIV-TRePS system: the development and evaluation of new global and local computational models to predict HIV treatment outcomes, with or without a genotype. Journal of Antimicrobial Chemotherapy. 71(10). 2928–2937. 6 indexed citations

7.

Revell, Andrew, Sean Emery, Dechao Wang, et al.. (2016). Computational models as predictors of HIV treatment outcomes for the Phidisa cohort in South Africa. Southern African Journal of HIV Medicine. 17(1). 450–450. 5 indexed citations

8.

Revell, Andrew, Sean Emery, Dechao Wang, et al.. (2016). Computational models as predictors of HIV treatment outcomes for the Phidisa cohort in South Africa. Southern African Journal of HIV Medicine. 17(1). 1 indexed citations

9.

Nel, Annaléne, Neliëtte van Niekerk, Allison Carter, et al.. (2014). Baseline Characteristics of HIV-negative Women Enrolled into the Ring Study - A Clinical Trial of the Dapivirine Vaginal Ring for HIV-1 Prevention. AIDS Research and Human Retroviruses. 30(S1). A289–A289. 1 indexed citations

10.

Schoffelen, Annelot F., Annemarie M. J. Wensing, Hugo Tempelman, et al.. (2013). Sustained Virological Response on Second-Line Antiretroviral Therapy following Virological Failure in HIV-Infected Patients in Rural South Africa. PLoS ONE. 8(3). e58526–e58526. 35 indexed citations

11.

Reid, Gregor, Remco Kort, Frank Schuren, et al.. (2011). PCR‐based identification of eight lactobacillus species and 18 hr‐HPV genotypes in fixed cervical samples of south african women at risk of HIV and BV. Diagnostic Cytopathology. 40(6). 472–477. 28 indexed citations

12.

Smit, Pieter W., Remco Kort, Gregor Reid, et al.. (2011). Microarray-based identification of clinically relevant vaginal bacteria in relation to bacterial vaginosis. American Journal of Obstetrics and Gynecology. 204(4). 305.e1–305.e7. 46 indexed citations

13.

Barth, Roos E., Susan C. Aitken, Hugo Tempelman, et al.. (2011). Accumulation of Drug Resistance and Loss of Therapeutic Options Precede Commonly Used Criteria for Treatment Failure in HIV-1 Subtype-C-Infected Patients. Antiviral Therapy. 17(2). 377–386. 45 indexed citations

14.

Barth, Roos E., et al.. (2010). Long-term Outcome of Children Receiving Antiretroviral Treatment in Rural South Africa. The Pediatric Infectious Disease Journal. 30(1). 52–56. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact